Tag: Milestone® Pharmaceuticals

Milestone® Pharmaceuticals ($MIST) Shares Drop Sharply Amid FDA Review Update

Milestone® Pharmaceuticals (NASDAQ: MIST) shares plunged sharply by 31.25% in pre-market trading on Friday, July 11, 2025, falling to $1.76. This steep drop comes...

Milestone Pharmaceuticals Inc. ($MIST) Advances CARDAMYST™ Nasal Spray FDA Review

Milestone® Pharmaceuticals Inc. (MIST) announced that the FDA has accepted for review the company’s response to the Complete Response Letter for CARDAMYST™ (etripamil) nasal...